Cochrane Reviews and Protocols related to Complementary Medicine

Here is a list, in alphabetical order, of the reviews and protocols that we have assessed as related to complementary or integrative medicine, which are currently available in the Cochrane Library.

Cochrane complementary medicine-related reviews as of January 1 2021

1. Acanthopanax for acute ischaemic stroke
2. Acetyl-l-carnitine for dementia
3. Acetyl‐L‐carnitine for patients with hepatic encephalopathy
4. Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
5. Acupuncture and acupressure for premenstrual syndrome
6. Acupuncture and assisted reproductive technology
7. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis
8. Acupuncture and related interventions for smoking cessation
9. Acupuncture and related interventions for symptoms of chronic kidney disease
10. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome
11. Acupuncture for acute hordeolum
12. Acupuncture for acute management and rehabilitation of traumatic brain injury
13. Acupuncture for acute stroke
14. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
15. Acupuncture for autism spectrum disorders (ASD)
16. Acupuncture for Bell's palsy
17. Acupuncture for cancer pain in adults
18. Acupuncture for chronic asthma
19. Acupuncture for chronic hepatitis B
20. Acupuncture for chronic nonspecific low back pain
21. Acupuncture for depression
22. Acupuncture for dysmenorrhoea
23. Acupuncture for dysphagia in acute stroke
24. Acupuncture for epilepsy
25. Acupuncture for functional dyspepsia
26. Acupuncture for glaucoma
27. Acupuncture for hip osteoarthritis
28. Acupuncture for hypertension
29. Acupuncture for hypoxic ischemic encephalopathy in neonates
30. Acupuncture for insomnia
31. Acupuncture for lateral elbow pain
32. Acupuncture for menopausal hot flushes
33. Acupuncture for mumps in children
34. Acupuncture for neuropathic pain in adults
35. Acupuncture for pain in endometriosis
36. Acupuncture for polycystic ovarian syndrome
37. Acupuncture for renal colic
38. Acupuncture for restless legs syndrome
39. Acupuncture for schizophrenia
40. Acupuncture for shoulder pain
41. Acupuncture for slowing the progression of myopia in children and adolescents
42. Acupuncture for stress urinary incontinence in adults
43. Acupuncture for stroke rehabilitation
44. Acupuncture for symptomatic gastroparesis
45. Acupuncture for the prevention of episodic migraine
46. Acupuncture for treating acute ankle sprains in adults
47. Acupuncture for treating fibromyalgia
48. Acupuncture for treatment of irritable bowel syndrome
49. Acupuncture for uterine fibroids
50. Acupuncture for vascular dementia
51. Acupuncture or acupressure for induction of labour
52. Acupuncture or acupressure for pain management during labour
53. Alcohol intake reduction for controlling hypertension
54. Alexander technique for chronic asthma
55. Aloe vera for prevention and treatment of infusion phlebitis
56. Aloe vera for treating acute and chronic wounds
57. Alpha lipoic acid for dementia
58. Altered dietary salt for preventing pre-eclampsia, and its complications
59. Altered dietary salt intake for people with chronic kidney disease
60. Altered dietary salt intake for preventing and treating diabetic kidney disease
61. Alternating current cranial electrotherapy stimulation (CES) for depression
62. Animal‐assisted therapy for dementia
63. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
64. Antenatal breast milk expression by women with diabetes for improving infant outcomes
65. Anti-spasticity agents for multiple sclerosis
66. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
67. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood
68. Antioxidant supplementation for lung disease in cystic fibrosis
69. Antioxidant supplements for liver diseases
70. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
71. Antioxidant supplements for preventing gastrointestinal cancers
72. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
73. Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease
74. Antioxidant treatments for schizophrenia
75. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
76. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
77. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract
78. Antioxidants for chronic kidney disease
79. Antioxidants for female subfertility
80. Antioxidants for male subfertility
81. Antioxidants for pain in chronic pancreatitis
82. Antioxidants for preventing and reducing muscle soreness after exercise
83. Antioxidants for preventing pre-eclampsia
84. Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
85. Aromatherapy for dementia
86. Aromatherapy for pain management in labour
87. Aromatherapy for treatment of postoperative nausea and vomiting
88. Art therapy for people with dementia
89. Art therapy for schizophrenia or schizophrenia-like illnesses
90. Assessment and support during early labour for improving birth outcomes
91. Assisted reproductive technology: an overview of Cochrane Reviews
92. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
93. Auricular acupuncture for cocaine dependence
94. Ayurvedic medicine for schizophrenia
95. Ayurvedic treatments for diabetes mellitus
96. Balneotherapy for chronic venous insufficiency
97. Balneotherapy for osteoarthritis
98. Balneotherapy for rheumatoid arthritis
99. Behavioural interventions for dysmenorrhoea
100. Behavioural therapies versus other psychological therapies for depression
101. Behavioural treatment for chronic low-back pain
102. Beta-sitosterols for benign prostatic hyperplasia
103. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults
104. Biofeedback for pain management during labour
105. Biofeedback for treatment of chronic idiopathic constipation in adults
106. Biofeedback for treatment of irritable bowel syndrome
107. Black cohosh (Cimicifuga spp.) for menopausal symptoms
108. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
109. Branched-chain amino acids for people with hepatic encephalopathy
110. Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour
111. Breathing exercises for adults with asthma
112. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
113. Caffeine as an analgesic adjuvant for acute pain in adults
114. Caffeine for asthma
115. Caffeine versus theophylline for apnea in preterm infants
116. Calcium and phosphorus supplementation of human milk for preterm infants
117. Calcium and vitamin D for corticosteroid-induced osteoporosis
118. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
119. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy
120. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
121. Calcium supplementation for improving bone mineral density in children
122. Calcium supplementation for the management of primary hypertension in adults
123. Calcium supplementation on bone loss in postmenopausal women
124. Calcium, vitamin D or recombinant parathyroid hormone for managing post‐thyroidectomy hypoparathyroidism
125. Calorie controlled diet for chronic asthma
126. Cannabinoids for epilepsy
127. Cannabinoids for fibromyalgia
128. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
129. Cannabinoids for the treatment of dementia
130. Cannabinoids for Tourette's Syndrome
131. Cannabis and schizophrenia
132. Cannabis for the treatment of Crohn's disease
133. Cannabis for the treatment of ulcerative colitis
134. Cannabis‐based medicines for chronic neuropathic pain in adults
135. Cardioprotective interventions for cancer patients receiving anthracyclines
136. Carnitine for fatigue in multiple sclerosis
137. Carnitine supplementation for inborn errors of metabolism
138. Carnitine supplementation for preterm infants with recurrent apnoea
139. Carnitine supplementation of parenterally fed neonates
140. Castor oil, bath and/or enema for cervical priming and induction of labour
141. Cephalic version by moxibustion for breech presentation
142. Chelation therapy for atherosclerotic cardiovascular disease
143. Chinese herbal medicine for atopic eczema
144. Chinese herbal medicine for chronic neck pain due to cervical degenerative disc disease
145. Chinese herbal medicine for diabetic peripheral neuropathy
146. Chinese herbal medicine for endometriosis
147. Chinese herbal medicine for menopausal symptoms
148. Chinese herbal medicine for oesophageal cancer
149. Chinese herbal medicine for premenstrual syndrome
150. Chinese herbal medicine for primary dysmenorrhoea
151. Chinese herbal medicine for schizophrenia
152. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
153. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome
154. Chinese herbal medicine in the treatment of ectopic pregnancy
155. Chinese herbal medicine suxiao jiuxin wan for angina pectoris
156. Chinese herbal medicines for acute pancreatitis
157. Chinese herbal medicines for benign thyroid nodules in adults
158. Chinese herbal medicines for esophageal cancer
159. Chinese herbal medicines for hypercholesterolemia
160. Chinese herbal medicines for hyperthyroidism
161. Chinese herbal medicines for hypertriglyceridaemia
162. Chinese herbal medicines for hypothyroidism
163. Chinese herbal medicines for induction of remission in advanced or late gastric cancer
164. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
165. Chinese herbal medicines for threatened miscarriage
166. Chinese herbal medicines for treating osteoporosis
167. Chinese herbal medicines for treating pre-eclampsia
168. Chinese herbal medicines for treating skin and soft-tissue infections
169. Chinese herbal medicines for type 2 diabetes mellitus
170. Chinese herbal medicines for unexplained recurrent miscarriage
171. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)
172. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
173. Chinese medicinal herbs for acute bronchitis
174. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
175. Chinese medicinal herbs for cholelithiasis
176. Chinese medicinal herbs for chronic hepatitis B
177. Chinese medicinal herbs for influenza
178. Chinese medicinal herbs for measles
179. Chinese medicinal herbs for mumps
180. Chinese medicinal herbs for sore throat
181. Chinese medicinal herbs for the common cold
182. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients
183. Chitosan for overweight or obesity
184. Chondroitin for osteoarthritis
185. Chromium picolinate supplementation for overweight or obese adults
186. Chuanxiong-type preparations for acute ischemic stroke
187. Cinnamon for diabetes mellitus
188. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease
189. Coenzyme Q10 for heart failure
190. Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
191. Cognitive behavioural therapy for tinnitus
192. Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise
193. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults
194. Combined chiropractic interventions for low-back pain
195. Combined diet and exercise interventions for preventing gestational diabetes mellitus
196. Combined vitamin B6-magnesium treatment in autism spectrum disorder
197. Complementary and alternative therapies for pain management in labour
198. Complementary and alternative therapies for post‐caesarean pain
199. Complementary and miscellaneous interventions for nocturnal enuresis in children
200. Complementary therapies for acne vulgaris
201. Conservative interventions for treating exercise-related musculotendinous, ligamentous and osseous groin pain
202. Conservative interventions for treating functional daytime urinary incontinence in children
203. Conservative management for postprostatectomy urinary incontinence
204. Continuous support for women during childbirth
205. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
206. Cranberries for preventing urinary tract infections
207. Cranberries for treating urinary tract infections
208. Creatine for amyotrophic lateral sclerosis/motor neuron disease
209. Creatine for Parkinson's disease
210. Creatine for treating muscle disorders
211. Creatine for women in pregnancy for neuroprotection of the fetus
212. Curcumin for maintenance of remission in ulcerative colitis
213. Cyclamen europaeum extract for acute sinusitis
214. Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
215. Daily oral iron supplementation during pregnancy
216. Dan Shen agents for acute ischaemic stroke
217. Dance movement therapy for dementia
218. Dance movement therapy for depression
219. Dance therapy for schizophrenia
220. Dance/movement therapy for improving psychological and physical outcomes in cancer patients
221. Danshen (Chinese medicinal herb) preparations for acute myocardial infarction
222. Deep brain and cortical stimulation for epilepsy
223. Deep transverse friction massage for treating tendinitis
224. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people
225. Dehydroepiandrosterone for systemic lupus erythematosus
226. Dehydroepiandrosterone for women in the peri- or postmenopausal phase
227. Dengzhanhua preparations for acute cerebral infarction
228. Diaries for recovery from critical illness
229. Dietary advice for reducing cardiovascular risk
230. Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
231. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
232. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas
233. Dietary fibre for the primary prevention of cardiovascular disease
234. Dietary flavonoid for preventing colorectal neoplasms
235. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia
236. Dietary interventions for adult cancer survivors
237. Dietary interventions for adults with chronic kidney disease
238. Dietary interventions for multiple sclerosis
239. Dietary interventions for multiple sclerosis‐related outcomes
240. Dietary interventions for preventing complications in idiopathic hypercalciuria
241. Dietary interventions for recurrent abdominal pain in childhood
242. Dietary interventions for rheumatoid arthritis
243. Dietary marine fatty acids (fish oil) for asthma in adults and children
244. Dietary sodium manipulation and asthma
245. Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes
246. Dietary supplements for chronic gout
247. Dietary supplements for dysmenorrhoea
248. Dietary supplements for established atopic eczema
249. Dietary supplements for preventing postnatal depression
250. Different methods for the induction of labour in outpatient settings
251. Different types of dietary advice for women with gestational diabetes mellitus
252. Drama therapy for schizophrenia or schizophrenia-like illnesses
253. Drugs for preventing lung cancer in healthy people
254. Early intervention for psychosis
255. Early skin-to-skin contact for mothers and their healthy newborn infants
256. Echinacea for preventing and treating the common cold
257. Effect of cocoa on blood pressure
258. Effects and safety of periconceptional folate supplementation for preventing birth defects
259. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
260. Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age
261. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome
262. Effects of total fat intake on body fatness in adults
263. Effects of total fat intake on bodyweight in children
264. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
265. Electrical stimulation for faecal incontinence in adults
266. Electrical stimulation for preventing and treating post-stroke shoulder pain
267. Electrical stimulation for the treatment of rheumatoid arthritis
268. Electrical stimulation for treating pressure ulcers
269. Electrical stimulation with non-implanted electrodes for overactive bladder in adults
270. Electrical stimulation with non-implanted electrodes for urinary incontinence in men
271. Electromagnetic fields for treating osteoarthritis
272. Electromagnetic therapy for treating pressure ulcers
273. Electromagnetic therapy for treating venous leg ulcers
274. Electrotherapy modalities for adhesive capsulitis (frozen shoulder)
275. Endometriosis: an overview of Cochrane Reviews
276. Enteral iron supplementation in preterm and low birth weight infants
277. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
278. Enteral nutrition for maintenance of remission in Crohn's disease
279. Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
280. Exercise for dysmenorrhoea
281. Exercise for preventing falls in older people living in the community
282. Exercise for rheumatoid arthritis of the hand
283. Exercise programs for people with dementia
284. Exercises for mechanical neck disorders
285. Fat supplementation of human milk for promoting growth in preterm infants
286. Fermented milk for hypertension
287. Feverfew for preventing migraine
288. Fish oil for induction of remission in ulcerative colitis
289. Fish oil for kidney transplant recipients
290. Flavonoids for treating venous leg ulcers
291. Folate for depressive disorders
292. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
293. Folic acid for fragile X syndrome
294. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes
295. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
296. Ganoderma lucidum (Reishi mushroom) for cancer treatment
297. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
298. Garlic for peripheral arterial occlusive disease
299. Garlic for preventing pre-eclampsia and its complications
300. Garlic for the common cold
301. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
302. Ginkgo biloba extract for age-related macular degeneration
303. Ginkgo biloba for acute ischaemic stroke
304. Ginkgo biloba for cognitive impairment and dementia
305. Ginkgo biloba for intermittent claudication
306. Ginseng for cognition
307. Glucosamine therapy for treating osteoarthritis
308. Glutamine supplementation for critically ill adults
309. Glutamine supplementation for young infants with severe gastrointestinal disease
310. Glutamine supplementation to prevent morbidity and mortality in preterm infants
311. Green and black tea for the primary prevention of cardiovascular disease
312. Green tea (Camellia sinensis) for the prevention of cancer
313. Green tea for weight loss and weight maintenance in overweight or obese adults
314. Guided imagery for treating hypertension in pregnancy
315. Hawthorn extract for treating chronic heart failure
316. Helminth therapy (worms) for allergic rhinitis
317. Helminth therapy (worms) for induction of remission in inflammatory bowel disease
318. Herbal interventions for chronic asthma in adults and children
319. Herbal medicinal products or preparations for neuropathic pain
320. Herbal medicine for low-back pain
321. Herbal medicines for fatty liver diseases
322. Herbal medicines for treating HIV infection and AIDS
323. Herbal medicines for treatment of irritable bowel syndrome
324. Herbal preparations for uterine fibroids
325. Herbal therapy for treating rheumatoid arthritis
326. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
327. Homeopathic medicines for adverse effects of cancer treatments
328. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness
329. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
330. Homeopathy for chronic asthma
331. Homeopathy for dementia
332. Homeopathy for treatment of irritable bowel syndrome
333. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
334. Homocysteine-lowering interventions for preventing cardiovascular events
335. Homoeopathy for induction of labour
336. Honey and lozenges for children with non-specific cough
337. Honey as a topical treatment for wounds
338. Honey for acute cough in children
339. Horse chestnut seed extract for chronic venous insufficiency
340. Horticultural therapy for schizophrenia
341. Huperzine A for Alzheimer's disease
342. Huperzine A for mild cognitive impairment
343. Huperzine A for vascular dementia
344. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
345. Hyperbaric oxygen therapy for acute coronary syndrome
346. Hyperbaric oxygen therapy for acute ischaemic stroke
347. Hyperbaric oxygen therapy for Bell's palsy
348. Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury
349. Hyperbaric oxygen therapy for multiple sclerosis
350. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD)
351. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
352. Hyperbaric oxygen therapy for vascular dementia
353. Hyperbaric oxygenation for tumour sensitisation to radiotherapy
354. Hypnosis during pregnancy, childbirth, and the postnatal period for preventing postnatal depression
355. Hypnosis for induction of labour
356. Hypnosis for schizophrenia
357. Hypnotherapy for smoking cessation
358. Hypnotherapy for treatment of irritable bowel syndrome
359. Immersion in water during labour and birth
360. Immunonutrition as an adjuvant therapy for burns
361. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
362. Immunonutrition for patients undergoing surgery for head and neck cancer
363. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases
364. Inositol for depressive disorders
365. Inositol for subfertile women with polycystic ovary syndrome
366. Inositol in preterm infants at risk for or having respiratory distress syndrome
367. Intercessory prayer for the alleviation of ill health
368. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression
369. Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews
370. Interventions for apathy after traumatic brain injury
371. Interventions for bone disease in children with chronic kidney disease
372. Interventions for bullous pemphigoid
373. Interventions for chronic kidney disease-associated restless legs syndrome
374. Interventions for chronic palmoplantar pustulosis
375. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy
376. Interventions for cutaneous molluscum contagiosum
377. Interventions for drug‐using offenders with co‐occurring mental health problems
378. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury
379. Interventions for erosive lichen planus affecting mucosal sites
380. Interventions for fatigue in inflammatory bowel disease
381. Interventions for fatigue in peripheral neuropathy
382. Interventions for improving mobility after hip fracture surgery in adults
383. Interventions for improving sleep quality in people with chronic kidney disease
384. Interventions for improving upper limb function after stroke
385. Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment
386. Interventions for ingrowing toenails
387. Interventions for itch in people with advanced chronic kidney disease
388. Interventions for leg cramps in pregnancy
389. Interventions for lowering plasma homocysteine levels in dialysis patients
390. Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
391. Interventions for managing asthma in pregnancy
392. Interventions for managing taste disturbances
393. Interventions for nausea and vomiting in early pregnancy
394. Interventions for pityriasis rosea
395. Interventions for preventing and treating pelvic and back pain in pregnancy
396. Interventions for preventing bone disease in kidney transplant recipients
397. Interventions for preventing falls in older people in care facilities and hospitals
398. Interventions for preventing falls in older people living in the community
399. Interventions for preventing falls in people after stroke
400. Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological interventions
401. Interventions for preventing infection in nephrotic syndrome
402. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section
403. Interventions for preventing oral mucositis for patients with cancer receiving treatment
404. Interventions for prevention of post-operative recurrence of Crohn's disease
405. Interventions for primary vesicoureteric reflux
406. Interventions for prodromal stage of psychosis
407. Interventions for reducing anxiety in women undergoing colposcopy
408. Interventions for reducing inflammation in familial Mediterranean fever
409. Interventions for replacing missing teeth: hyperbaric oxygen therapy for irradiated patients who require dental implants
410. Interventions for the management of dry mouth: non-pharmacological interventions
411. Interventions for the management of oral submucous fibrosis
412. Interventions for the management of temporomandibular joint osteoarthritis
413. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
414. Interventions for treating anxiety after stroke
415. Interventions for treating burning mouth syndrome
416. Interventions for treating collagenous colitis
417. Interventions for treating constipation in pregnancy
418. Interventions for treating hyperemesis gravidarum
419. Interventions for treating leg ulcers in people with sickle cell disease
420. Interventions for treating oral leukoplakia to prevent oral cancer
421. Interventions for treating painful nipples among breastfeeding women
422. Interventions for treating persistent pain in survivors of torture
423. Interventions for treating sexual dysfunction in patients with chronic kidney disease
424. Interventions for treating urinary incontinence after stroke in adults
425. Interventions to facilitate return to work in adults with adjustment disorders
426. Interventions to improve psychosocial well‐being in female BRCA‐mutation carriers following risk‐reducing surgery
427. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews
428. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers
429. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
430. Iodine supplementation for women during the preconception, pregnancy and postpartum period
431. Iron for the treatment of restless legs syndrome
432. Iron supplementation for breath-holding attacks in children
433. Iron supplementation for reducing morbidity and mortality in children with HIV
434. Isoflavones for hypercholesterolaemia in adults
435. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
436. Kava extract versus placebo for treating anxiety
437. Ketogenic diets for drug‐resistant epilepsy
438. L-carnitine for cognitive enhancement in people without cognitive impairment
439. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
440. Lactose avoidance for young children with acute diarrhoea
441. Laetrile treatment for cancer
442. Lecithin for dementia and cognitive impairment
443. Lifestyle interventions for acute gout
444. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
445. Light therapy for non-seasonal depression
446. Light therapy for preventing seasonal affective disorder
447. Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes
448. Local cooling for relieving pain from perineal trauma sustained during childbirth
449. Long chain polyunsaturated fatty acid supplementation in infants born at term
450. Longchain polyunsaturated fatty acid supplementation in preterm infants
451. Low glycaemic index diets for the prevention of cardiovascular disease
452. Low glycaemic index or low glycaemic load diets for overweight and obesity
453. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
454. Low protein diets for non‐diabetic adults with chronic kidney disease
455. Low-fat diets for acquired hypercholesterolaemia
456. Lycopene for the prevention of prostate cancer
457. Magnesium for alcohol withdrawal
458. Magnesium for skeletal muscle cramps
459. Magnesium for treating sickle cell disease
460. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
461. Magnesium supplementation for the management of primary hypertension in adults
462. Magnesium supplementation in pregnancy
463. Mailuoning for acute ischaemic stroke
464. Management of gag reflex for patients undergoing dental treatment
465. Manipulative therapies for infantile colic
466. Manual therapy and exercise for adhesive capsulitis (frozen shoulder)
467. Manual therapy for asthma
468. Marine‐derived n‐3 fatty acids therapy for stroke
469. Massage and touch for dementia
470. Massage for low-back pain
471. Massage for mechanical neck disorders
472. Massage for promoting growth and development of preterm and/or low birth-weight infants
473. Massage for promoting mental and physical health in typically developing infants under the age of six months
474. Massage therapy for people with HIV/AIDS
475. Massage with or without aromatherapy for symptom relief in people with cancer
476. Massage, reflexology and other manual methods for pain management in labour
477. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child
478. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants
479. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
480. Medicinal herbs for hepatitis C virus infection
481. Meditation for adults with haematological malignancies
482. Meditation therapies for attention-deficit/hyperactivity disorder (ADHD)
483. Meditation therapy for anxiety disorders
484. Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease
485. Melatonin and agomelatine for preventing seasonal affective disorder
486. Melatonin as add-on treatment for epilepsy
487. Melatonin for non-respiratory sleep disorders in visually impaired children
488. Melatonin for the prevention and treatment of jet lag
489. Melatonin for the promotion of sleep in adults in the intensive care unit
490. Melatonin for the treatment of dementia
491. Melatonin for women in pregnancy for neuroprotection of the fetus
492. Methods of milk expression for lactating women
493. Micronutrient supplementation in adults with HIV infection
494. Micronutrient supplementation in pregnant women with HIV infection
495. Midwife-led continuity models versus other models of care for childbearing women
496. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
497. Mind-body interventions during pregnancy for preventing or treating women's anxiety
498. Mindfulness‐based stress reduction for family carers of people with dementia
499. Mindfulness‐based stress reduction for women diagnosed with breast cancer
500. Mistletoe therapy in oncology
501. Momordica charantia for type 2 diabetes mellitus
502. Monosodium glutamate avoidance for chronic asthma in adults and children
503. Morita therapy for anxiety disorders in adults
504. Morita therapy for schizophrenia
505. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer
506. Multinutrient fortification of human breast milk for preterm infants following hospital discharge
507. Muscle energy technique for non-specific low-back pain
508. Music during caesarean section under regional anaesthesia for improving maternal and infant outcomes
509. Music for stress and anxiety reduction in coronary heart disease patients
510. Music interventions for acquired brain injury
511. Music interventions for improving psychological and physical outcomes in cancer patients
512. Music interventions for mechanically ventilated patients
513. Music interventions for preoperative anxiety
514. Music therapy for depression
515. Music therapy for people with autism spectrum disorder
516. Music therapy for people with schizophrenia and schizophrenia-like disorders
517. Music‐based therapeutic interventions for people with dementia
518. N-acetylcarnosine (NAC) drops for age-related cataract
519. N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
520. N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure
521. Neuromodulators for pain management in rheumatoid arthritis
522. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
523. Neuromuscular electrical stimulation for the prevention of venous thromboembolism
524. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
525. Niacin for primary and secondary prevention of cardiovascular events
526. Nicotine for schizophrenia
527. Nidotherapy for people with schizophrenia
528. Non surgical therapy for anal fissure
529. Non-clinical interventions for reducing unnecessary caesarean section
530. Non-drug therapies for lower limb muscle cramps
531. Non-hormonal interventions for hot flushes in women with a history of breast cancer
532. Non-invasive brain stimulation techniques for chronic pain
533. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer
534. Non-pharmacological interventions for alleviating pain during orthodontic treatment
535. Non-pharmacological interventions for chronic pain in people with spinal cord injury
536. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment
537. Non-pharmacological interventions for epilepsy in people with intellectual disabilities
538. Non-pharmacological interventions for fatigue in rheumatoid arthritis
539. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults
540. Non-surgical interventions for the management of chronic pelvic pain
541. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome
542. Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
543. Non‐clinical interventions for reducing unnecessary caesarean section
544. Non‐pharmacological interventions for chronic pain in multiple sclerosis
545. Normobaric and hyperbaric oxygen therapy for migraine and cluster headache
546. Nutrient-enriched formula milk versus human breast milk for preterm infants following hospital discharge
547. Nutrient-enriched formula versus standard formula for preterm infants following hospital discharge
548. Nutritional interventions for liver-transplanted patients
549. Nutritional interventions for preventing and treating pressure ulcers
550. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy
551. Nutritional interventions for reducing morbidity and mortality in people with HIV
552. Nutritional interventions for survivors of childhood cancer
553. Nutritional interventions for treating foot ulcers in people with diabetes
554. Nutritional supplementation for hip fracture aftercare in older people
555. Nutritional supplementation for stable chronic obstructive pulmonary disease
556. Nutritional supplements for patients being treated for active visceral leishmaniasis
557. Nutritional supplements for people being treated for active tuberculosis
558. Nutritional support for acute kidney injury
559. Nutritional support for liver disease
560. Omega 3 fatty acid for the prevention of cognitive decline and dementia
561. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
562. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis
563. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration
564. Omega-3 fatty acids for bipolar disorder
565. Omega-3 fatty acids for the treatment of dementia
566. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD)
567. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
568. Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye disease
569. Omega‐3 fatty acid addition during pregnancy
570. Omega‐3 fatty acid supplementation for cystic fibrosis
571. Omega‐3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease
572. Omega‐3 fatty acids for intermittent claudication
573. Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
574. Omega‐6 fats for the primary and secondary prevention of cardiovascular disease
575. Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
576. Oral evening primrose oil and borage oil for eczema
577. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
578. Oral herbal therapies for treating osteoarthritis
579. Oral immunotherapy for milk allergy
580. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
581. Oral protein‐based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis
582. Oral traditional Chinese medication for adhesive small bowel obstruction
583. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
584. Oral zinc for arterial and venous leg ulcers
585. Oral zinc for treating diarrhoea in children
586. Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates
587. Over-the-counter (OTC) medications for acute cough in children and adults in community settings
588. Padma 28 for intermittent claudication
589. Pain management for women in labour: an overview of systematic reviews
590. Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment
591. Pain-relieving agents for infantile colic
592. Pancreatic enzymes for chronic pancreatitis
593. Parent-infant psychotherapy for improving parental and infant mental health
594. Parenteral versus oral iron therapy for adults and children with chronic kidney disease
595. Participation in environmental enhancement and conservation activities for health and well-being in adults: a review of quantitative and qualitative evidence
596. Participation of traditional, complementary and alternative health practitioners in conventional health systems in low‐ and middle‐income countries
597. Passiflora for anxiety disorder
598. Pelargonium sidoides extract for treating acute respiratory tract infections
599. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women
600. Perceptions and experiences of labour companionship: a qualitative evidence synthesis
601. Peri-operative glycaemic control regimens for preventing surgical site infections in adults
602. Perianal injectable bulking agents as treatment for faecal incontinence in adults
603. Person-directed, non-pharmacological interventions for sleepiness at work and sleep disturbances caused by shift work
604. Pharmacological agents for adults with acute respiratory distress syndrome
605. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
606. Pharmacological interventions for borderline personality disorder
607. Pharmacological interventions for clozapine-induced hypersalivation
608. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work
609. Pharmacological interventions for somatoform disorders in adults
610. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy
611. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome
612. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain‐Barré syndrome
613. Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
614. Pharmacotherapies for cannabis dependence
615. Pharmacotherapies for sleep disturbances in dementia
616. Phlebotonics for haemorrhoids
617. Phlebotonics for venous insufficiency
618. Phyllanthus species for chronic hepatitis B virus infection
619. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
620. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews
621. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction
622. Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer
623. Physical therapies for postural abnormalities in people with cystic fibrosis
624. Phytoestrogens for menopausal vasomotor symptoms
625. Phytomedicines (medicines derived from plants) for sickle cell disease
626. Pilates for low back pain
627. Pine bark (Pinus spp.) extract for treating chronic disorders
628. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy
629. Polyunsaturated fatty acid supplementation for schizophrenia
630. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
631. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
632. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
633. Postnatal thyroid hormones for respiratory distress syndrome in preterm infants
634. Potassium supplementation for the management of primary hypertension in adults
635. Prebiotics for the prevention of hyperbilirubinaemia in neonates
636. Prebiotics in infants for prevention of allergy
637. Prescribed hypocaloric nutrition support for critically-ill adults
638. Preventing occupational stress in healthcare workers
639. Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well‐being
640. Probiotics for induction of remission in Crohn's disease
641. Probiotics for induction of remission in ulcerative colitis
642. Probiotics for maintenance of remission in Crohn's disease
643. Probiotics for maintenance of remission in ulcerative colitis
644. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
645. Probiotics for people with cystic fibrosis
646. Probiotics for people with hepatic encephalopathy
647. Probiotics for preventing acute otitis media in children
648. Probiotics for preventing acute upper respiratory tract infections
649. Probiotics for preventing gestational diabetes
650. Probiotics for preventing preterm labour
651. Probiotics for preventing urinary tract infection in people with neuropathic bladder
652. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
653. Probiotics for the prevention of pediatric antibiotic‐associated diarrhea
654. Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer
655. Probiotics for the treatment of bacterial vaginosis
656. Probiotics for the treatment of irritable bowel syndrome in children
657. Probiotics for treating acute infectious diarrhoea
658. Probiotics for treating eczema
659. Probiotics for treating persistent diarrhoea in children
660. Probiotics for treatment of Clostridium difficile-associated colitis in adults
661. Probiotics for vulvovaginal candidiasis in non-pregnant women
662. Probiotics in infants for prevention of allergic disease and food hypersensitivity
663. Probiotics to prevent infantile colic
664. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
665. Procaine treatments for cognition and dementia
666. Prolotherapy injections for chronic low-back pain
667. Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infants
668. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants
669. Protein restriction for children with chronic kidney disease
670. Protein restriction for diabetic renal disease
671. Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused
672. Psychological and behavioural treatments for adults with non-epileptic attack disorder
673. Psychological and educational interventions for atopic eczema in children
674. Psychological interventions for acute pain after open heart surgery
675. Psychological interventions for coronary heart disease
676. Psychological interventions for needle‐related procedural pain and distress in children and adolescents
677. Psychological interventions for people with hemophilia
678. Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
679. Psychological interventions to foster resilience in healthcare professionals
680. Psychological interventions to foster resilience in healthcare students
681. Psychological preparation and postoperative outcomes for adults undergoing surgery under general anaesthesia
682. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents
683. Psychological therapies for children and adolescents exposed to trauma
684. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis
685. Psychological therapies for pathological and problem gambling
686. Psychological therapies for people with borderline personality disorder
687. Psychological therapies for preventing seasonal affective disorder
688. Psychological therapies for the management of chronic and recurrent pain in children and adolescents
689. Psychological therapies for the management of chronic pain (excluding headache) in adults
690. Psychological therapies for the prevention of migraine in adults
691. Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises
692. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents
693. Psychological therapies for treatment-resistant depression in adults
694. Psychological therapies for women who experience intimate partner violence
695. Psychological treatments for people with epilepsy
696. Psychosocial group interventions to improve psychological well-being in adults living with HIV
697. Psychosocial interventions for conversion and dissociative disorders in adults
698. Psychosocial interventions for preventing and treating depression in dialysis patients
699. Psychosocial interventions for recurrent abdominal pain in childhood
700. Psychosocial interventions for self-harm in adults
701. Puerarin for ischaemic stroke
702. Pygeum africanum for benign prostatic hyperplasia
703. Pyridoxine (vitamin B6) supplementation in pregnancy
704. Quinine for muscle cramps
705. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B
706. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B
707. Reduced dietary salt for the prevention of cardiovascular disease
708. Reduced or modified dietary fat for preventing cardiovascular disease
709. Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy
710. Reduction in saturated fat intake for cardiovascular disease
711. Regimens of vitamin D supplementation for women during pregnancy
712. Rehabilitation following carpal tunnel release
713. Relaxation for depression
714. Relaxation for perimenopausal and postmenopausal symptoms
715. Relaxation techniques for pain management in labour
716. Relaxation therapies for the management of primary hypertension in adults
717. Relaxation therapy for preventing and treating preterm labour
718. Relief of pain due to uterine cramping/involution after birth
719. Reminiscence therapy for dementia
720. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults
721. Repetitive transcranial magnetic stimulation for improving function after stroke
722. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease
723. Repetitive transcranial magnetic stimulation for tinnitus
724. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
725. Resveratrol for adults with type 2 diabetes mellitus
726. Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
727. Roselle for hypertension in adults
728. Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
729. Rutosides for prevention of post‐thrombotic syndrome
730. Rutosides for treatment of post‐thrombotic syndrome
731. S-adenosyl methionine (SAMe) for depression in adults
732. S-adenosyl-L-methionine for alcoholic liver diseases
733. S-Adenosylmethionine for osteoarthritis of the knee or hip
734. Salicylate-containing rubefacients for acute and chronic musculoskeletal pain in adults
735. Sanchi for acute ischaemic stroke
736. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients
737. Selenium for preventing cancer
738. Selenium supplementation for asthma
739. Selenium supplementation for critically ill adults
740. Selenium supplementation for Hashimoto's thyroiditis
741. Selenium supplementation for the primary prevention of cardiovascular disease
742. Selenium supplementation to prevent short-term morbidity in preterm neonates
743. Sensory environment on health-related outcomes of hospital patients
744. Serenoa repens for benign prostatic hyperplasia
745. Simulated presence therapy for dementia
746. Singing as an adjunct therapy for children and adults with cystic fibrosis
747. Singing for adults with chronic obstructive pulmonary disease (COPD)
748. Singing for children and adults with bronchiectasis
749. Single dose oral ibuprofen plus caffeine for acute postoperative pain in adults
750. Single herbal medicine for diabetic retinopathy
751. Skin-to-skin care for procedural pain in neonates
752. Smectite for acute infectious diarrhoea in children
753. Snoezelen for dementia
754. Souvenaid for Alzheimer's disease
755. Speleotherapy for asthma
756. Spinal manipulation for dysmenorrhoea
757. Spinal manipulative therapy for acute low-back pain
758. Spinal manipulative therapy for chronic low-back pain
759. Spiritual and religious interventions for well-being of adults in the terminal phase of disease
760. Sports and games for post-traumatic stress disorder (PTSD)
761. St John's wort for major depression
762. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age
763. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting
764. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants
765. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development
766. Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement
767. Swallowing therapy for dysphagia in acute and subacute stroke
768. Sweet potato for type 2 diabetes mellitus
769. Tai Chi for chronic obstructive pulmonary disease (COPD)
770. Tai chi for primary prevention of cardiovascular disease
771. Tai Chi for rheumatoid arthritis
772. Tea tree oil for Demodex blepharitis
773. Testosterone for schizophrenia
774. Therapeutic touch for anxiety disorders
775. Therapeutic ultrasound for chronic low back pain
776. Thermotherapy for treating rheumatoid arthritis
777. Thermotherapy for treatment of osteoarthritis
778. Thiamine for Alzheimer's disease
779. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol
780. 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depression
781. 'Third wave' cognitive and behavioural therapies versus treatment as usual for depression
782. Thymic peptides for treatment of cancer patients
783. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery
784. Thyroid hormones for acute kidney injury
785. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants
786. Tianma Gouteng Yin Formula for treating primary hypertension
787. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris
788. Tongxinluo capsule for acute stroke
789. Topical analgesia for acute otitis media
790. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews
791. Topical capsaicin (high concentration) for chronic neuropathic pain in adults
792. Topical capsaicin (low concentration) for chronic neuropathic pain in adults
793. Topical herbal therapies for treating osteoarthritis
794. Topical treatments for chronic plaque psoriasis
795. Traditional Chinese herbal medicine for vascular dementia
796. Traditional Chinese herbal products for stable angina
797. Traditional Chinese Medicine herbs for stopping bleeding from haemorrhoids
798. Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
799. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke
800. Transcranial direct current stimulation (tDCS) for improving aphasia in patients after stroke
801. Transcranial magnetic stimulation for the treatment of epilepsy
802. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder
803. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults
804. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain
805. Transcutaneous Electrical Nerve Stimulation (TENS) for dementia
806. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults
807. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults
808. Transcutaneous electrical nerve stimulation (TENS) for pain management in labour
809. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease
810. Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults
811. Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand
812. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain
813. Transcutaneous electrical nerve stimulation for acute pain
814. Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
815. Transcutaneous electrical stimulation (TES) for treatment of constipation in children
816. Transcutaneous electrostimulation for osteoarthritis of the knee
817. Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studies)
818. Treatment for ataxia in multiple sclerosis
819. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
820. Treatment for mitochondrial disorders
821. Treatment for osteoporosis in people with ß-thalassaemia
822. Treatment for postpolio syndrome
823. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease
824. Treatments for breast engorgement during lactation
825. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
826. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome
827. Tryptophan and 5-Hydroxytryptophan for depression
828. Tyrosine supplementation for phenylketonuria
829. Uterine massage for preventing postpartum haemorrhage
830. Valerian for anxiety disorders
831. Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
832. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
833. Vitamin A for non-measles pneumonia in children
834. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
835. Vitamin A for treating measles in children
836. Vitamin A supplementation during pregnancy for maternal and newborn outcomes
837. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
838. Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
839. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants
840. Vitamin A supplements for reducing mother-to-child HIV transmission
841. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
842. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
843. Vitamin B and its derivatives for diabetic kidney disease
844. Vitamin B for treating peripheral neuropathy
845. Vitamin B6 for cognition
846. Vitamin B12 for cognition
847. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy
848. Vitamin C for asthma and exercise-induced bronchoconstriction
849. Vitamin C for preventing and treating pneumonia
850. Vitamin C for preventing and treating tetanus
851. Vitamin C for preventing and treating the common cold
852. Vitamin C supplementation for prevention and treatment of pneumonia
853. Vitamin C supplementation for the primary prevention of cardiovascular disease
854. Vitamin C supplementation in pregnancy
855. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
856. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
857. Vitamin D compounds for people with chronic kidney disease not requiring dialysis
858. Vitamin D compounds for people with chronic kidney disease requiring dialysis
859. Vitamin D for the management of asthma
860. Vitamin D for the management of multiple sclerosis
861. Vitamin D for the treatment of chronic painful conditions in adults
862. Vitamin D supplementation for cystic fibrosis
863. Vitamin D supplementation for improving bone mineral density in children
864. Vitamin D supplementation for preventing infections in children under five years of age
865. Vitamin D supplementation for prevention of cancer in adults
866. Vitamin D supplementation for prevention of mortality in adults
867. Vitamin D supplementation for sickle cell disease
868. Vitamin D supplementation for women during pregnancy
869. Vitamin E for Alzheimer's dementia and mild cognitive impairment
870. Vitamin E for intermittent claudication
871. Vitamin E for neuroleptic-induced tardive dyskinesia
872. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants
873. Vitamin E supplementation in people with cystic fibrosis
874. Vitamin E supplementation in pregnancy
875. Vitamin K for improved anticoagulation control in patients receiving warfarin
876. Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseases
877. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
878. Vitamin K supplementation for cystic fibrosis
879. Vitamin supplementation for preventing miscarriage
880. Vitamins C and E for asthma and exercise-induced bronchoconstriction
881. Vitamins for epilepsy
882. Water for preventing urinary stones
883. Water for wound cleansing
884. Weight loss interventions for chronic asthma
885. Wendan decoction (Traditional Chinese medicine) for schizophrenia
886. Whole grain cereals for the primary or secondary prevention of cardiovascular disease
887. Whole grain foods for the prevention of type 2 diabetes mellitus
888. Workplace interventions for reducing sitting at work
889. Wound cleansing for pressure ulcers
890. Written emotional disclosure for asthma
891. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
892. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
893. Xuebijing for paraquat poisoning
894. Xylitol for preventing acute otitis media in children up to 12 years of age
895. Yizhi capsule for vascular dementia
896. Yoga as part of a package of care versus non‐standard care for schizophrenia
897. Yoga as part of a package of care versus standard care for schizophrenia
898. Yoga for asthma
899. Yoga for epilepsy
900. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer
901. Yoga for secondary prevention of coronary heart disease
902. Yoga for the primary prevention of cardiovascular disease
903. Yoga for treating urinary incontinence in women
904. Yoga in addition to standard care for patients with haematological malignancies
905. Yoga treatment for chronic non-specific low back pain
906. Yoga versus non-standard care for schizophrenia
907. Yoga versus standard care for schizophrenia
908. Zhiling decoction for vascular dementia
909. Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
910. Zinc supplementation for improving pregnancy and infant outcome
911. Zinc supplementation for mental and motor development in children
912. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
913. Zinc supplementation for the prevention of type 2 diabetes mellitus
914. Zinc supplementation for tinnitus
915. Zinc supplements for preventing otitis media
916. Zinc supplements for treating thalassaemia and sickle cell disease

Cochrane complementary medicine-related protocols as of January 1 2021

1. Abdominal massage for the treatment of constipation
2. Acetyl-L-carnitine for the treatment of diabetic polyneuropathy
3. Acupoint stimulation for postoperative ileus following gastrointestinal surgery
4. Acupuncture for (sub)acute non-specific low-back pain
5. Acupuncture for adults with type 2 diabetes mellitus
6. Acupuncture for angina pectoris
7. Acupuncture for chronic constipation
8. Acupuncture for chronic neck pain
9. Acupuncture for female subfertility
10. Acupuncture for Gilles de la Tourette's syndrome
11. Acupuncture for Guillain-Barré syndrome
12. Acupuncture for Parkinson's Disease
13. Acupuncture for primary hypercholesterolaemia
14. Acupuncture for sudden idiopathic sensorineural hearing loss
15. Acupuncture for symptomatic treatment of diabetic peripheral neuropathy
16. Acupuncture for the prevention of tension-type headache
17. Acupuncture for the treatment of post-operative pain
18. Acupuncture for treating overactive bladder in adults
19. Acupuncture for treatment-related side effects in women with breast cancer
20. Acupuncture for turning a breech baby in pregnancy
21. Adjunctive Peony-Glycyrrhiza Decoction for antipsychotic-induced hyperprolactinemia
22. Alpha-lipoic acid for diabetic peripheral neuropathy
23. Alpha‐lipoic acid for hypertension in adults
24. Alternative prophylactic therapies (acupuncture and/or moxibustion) for reducing blood loss in the third stage of labour
25. Animal-assisted therapy for people with serious mental illness
26. Animal‐assisted therapy, including animal‐assisted activities and resident animals, for improving quality of life in people with stroke
27. Antioxidant supplementation for sickle cell disease
28. Antioxidants for acute pancreatitis
29. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline
30. Behavioural therapies versus treatment as usual for depression
31. Calcium and vitamin D for increasing bone mineral density in premenopausal women
32. Calcium supplementation for prevention of primary hypertension
33. Calcium supplementation for weight reduction in overweight or obese people
34. Cannabis and cannabinoids for people with multiple sclerosis
35. Capsaicin for non-allergic rhinitis
36. Carbohydrate or fat-restricted diets for obesity
37. Carnitine supplements for people with chronic kidney disease requiring dialysis
38. Chelation for autism spectrum disorder (ASD)
39. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions
40. Chinese herbal medicine for advanced pancreatic cancer
41. Chinese herbal medicine for treating recurrent urinary tract infections in women
42. Chinese herbal medicines for treating gestational diabetes mellitus
43. Chinese medicinal herbs for vaginal bleeding of medical abortion
44. Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer
45. Citicoline (CDP-choline) for traumatic brain injury
46. Combined large neutral amino acid supplementation for phenylketonuria (PKU)
47. Complementary and alternative therapies for shortening labour
48. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients
49. Cordyceps sinensis for hypertension in adults
50. Coriolus versicolor mushroom for colorectal cancer treatment
51. Cranberries for treating asymptomatic bacteriuria during pregnancy
52. Dietary advice for schizophrenia
53. Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
54. Different strains of probiotics for preventing morbidity and mortality in preterm infants: a network meta-analysis
55. EEG neurofeedback for executive functions in children with neurodevelopmental challenges
56. Effects of a gluten‐reduced or gluten‐free diet for the primary prevention of cardiovascular disease
57. Effects of preventive oral supplementation with iron or iron with folic acid for women following childbirth
58. Electrical stimulation with non-implanted devices for stress urinary incontinence in women
59. Electrotherapy modalities for lateral elbow pain
60. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates
61. Ephedrine for myasthenia gravis
62. Essential phospholipids for people with non‐alcoholic fatty liver disease
63. Fecal microbiota transplantation for treatment of irritable bowel syndrome
64. Fiber and bulking agents for the treatment of chronic constipation
65. Fish oil supplements for rheumatoid arthritis
66. Fish oil supplements for the prevention and treatment of hypertension in adults
67. Fish oil-based lipid emulsions versus standard lipid emulsions for prevention of parenteral nutrition-associated liver disease in children
68. Fish oil-based lipid emulsions versus standard lipid emulsions for treatment of parenteral nutrition-associated liver disease in children
69. Folate supplementation in patients with sickle cell disease
70. Folate supplementation in people with sickle cell disease
71. Ginkgo biloba for tinnitus
72. Ginkgo biloba versus placebo for schizophrenia
73. Ginseng for erectile dysfunction
74. Ginseng for improving the quality of life in people with cancer
75. Glutamine for induction of remission in Crohn's disease
76. Glycyrrhizin for chronic hepatitis B virus infection
77. Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection
78. Helminths for asthma
79. Herbal (non‐Chinese) medicines for functional dyspepsia
80. Herbal medicines for systemic lupus erythematosus
81. Herbal medicines for the treatment of inflammatory bowel disease
82. Herbal medicines for type 1 diabetes mellitus
83. Herbal preparations for weight loss in adults
84. Homeopathy for osteoarthritis
85. Humanistic therapies versus other psychological therapies for depression
86. Humanistic therapies versus treatment as usual for depression
87. Humour‐based interventions for people with schizophrenia
88. Hyperbaric oxygen therapy for persistent post-concussion syndrome following mild traumatic brain injury
89. Hypnosis for pain management during labour and childbirth
90. Hypnosis for preventing preterm labour
91. Intermittent fasting for the prevention of cardiovascular disease
92. Interventions (other than psychosocial, psychological and pharmacological) for treating postpartum depression
93. Interventions for helping people recognise early signs of recurrence in depression
94. Intranasal oxytocin for autism spectrum disorders (ASD)
95. Intranasal phototherapy for allergic rhinitis
96. Ketogenic diet for primary brain and spinal cord tumours
97. L-acetylcarnitine for fragile X syndrome
98. Lactoferrin for the post-operative management of term neonates after gastrointestinal surgery
99. Leeches (Hirudinea) for osteoarthritis
100. Listening to music for improving sleep in adults with insomnia
101. Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk
102. Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants
103. Magnetic seizure therapy for people with schizophrenia
104. Manual therapy and exercise for lateral elbow pain
105. Manual therapy with exercise for neck pain
106. Marine oil supplements for rheumatoid arthritis
107. Massage therapy for preventing pressure ulcers
108. Maternal antenatal methylxanthine (including caffeine) treatment for improving preterm outcomes
109. Maternal prenatal and/or postnatal n-3 fish oil supplementation for preventing allergies in early childhood
110. The McKenzie method for (sub)acute non-specific low-back pain
111. The McKenzie method for chronic non-specific low-back pain
112. Medicinal herbs for acute hepatitis B
113. Meditation for adult patients with haematological malignancies
114. Meditation for the primary and secondary prevention of cardiovascular disease
115. Melatonin for preoperative anxiety in adults
116. Melatonin for treating pre-eclampsia
117. Melatonin in cancer treatment
118. Mind-body movement therapies for Parkinson's disease
119. Mindfulness for smoking cessation
120. Mindfulness-based parenting programmes for improving psychosocial outcomes in children from birth to age 18 and their parents
121. Mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors
122. Modified dietary fat intake for treatment of gallstone disease
123. Moxibustion for stroke rehabilitation
124. Music for pain relief
125. Music therapy for people with substance use disorders
126. Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants
127. Myo-inositol for preventing gestational diabetes
128. Neuroaid for improving recovery after ischemic stroke
129. Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome
130. Non-hormonal therapy for hot flushes in postmenopausal women
131. Non-pharmacological interventions for managing dental anxiety in children
132. Non‐invasive brain stimulation for improving cognitive function in people with dementia and mild cognitive impairment
133. Nutritional supplementation for non‐alcohol‐related fatty liver disease: a network meta‐analysis
134. Omega 3 fatty acids for the treatment of dementia and cognitive impairment
135. Omega-3 fatty acids for depression in adults
136. Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease
137. Open Dialogue for psychosis or severe mental illness
138. Oral probiotics for infantile colic
139. Oral vitamin C supplements to prevent and treat acute upper respiratory tract infections
140. Oral zinc for the prevention of hyperbilirubinemia in neonates
141. Ozone therapy for treating diabetic foot ulcers
142. Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapy
143. Perioperative antioxidants for adults undergoing elective non‐cardiac surgery
144. Pharmacological interventions for self‐harm in adults
145. Physical activity for improving the symptoms of attention deficit hyperactivity disorder in children and adolescents
146. Physical interventions (orthoses, splints, exercise and manual therapy) for treating plantar heel pain
147. Phytoestrogens in the treatment of postmenopausal osteoporosis
148. Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy and food hypersensitivity
149. Preschool and school-based mindfulness programmes for improving mental health and cognitive functioning in young people aged 3 to 18 years
150. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection
151. Probiotics for fibromyalgia
152. Probiotics for preventing urinary tract infections in adults and children
153. Probiotics for preventing ventilator-associated pneumonia
154. Probiotics for the post-operative management of term neonates after gastrointestinal surgery
155. Probiotics for the prevention of Hirschsprung‐associated enterocolitis
156. Probiotics for the prevention or treatment of hyperbilirubinaemia in late preterm and term neonates
157. Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults
158. Psychodynamic therapies versus treatment as usual for depression
159. Qigong for the primary prevention of cardiovascular disease
160. Reflexology for treatment of constipation
161. Reiki treatment for psychological symptoms
162. Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome
163. Selenium supplementation during pregnancy for improving maternal and newborn outcomes
164. Singing for people with Parkinson's disease
165. Spiritual and religious interventions for adults with cancer and their carers: an overview of systematic reviews
166. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates
167. Synbiotics, prebiotics and probiotics for people with chronic kidney disease
168. Systemic nutritional interventions for treating foot ulcers in people with diabetes
169. Tai Chi for hypertension
170. Tai Chi for improving recovery after stroke
171. Tai chi for schizophrenia
172. Tai Chi plus standard care versus other exercise plus standard care for people with schizophrenia or related disorders
173. Testosterone supplementation for mild cognitive impairment and dementia
174. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention
175. Topical herbal interventions for gingivitis
176. Traditional Chinese medicinal herbs for condyloma acuminatum
177. Transcranial direct current stimulation (tDCS) for improving fatigue, motor function, and pain in people with multiple sclerosis
178. Transcranial laser therapy for acute ischemic stroke
179. Transcranial magnetic stimulation for schizophrenia
180. Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain
181. Transcutaneous electrical nerve stimulation (TENS) for pain control in women with primary dysmenorrhoea
182. Vegan diet for adults with overweight or obesity
183. Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases
184. Vitamin A supplementation for postpartum women
185. Vitamin A supplementation for prevention of mortality and morbidity in moderate and late preterm infants
186. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid life
187. Vitamin B for treating diabetic peripheral neuropathy
188. Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
189. Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults
190. Vitamin D for the management of chronic obstructive pulmonary disease
191. Vitamin D supplementation in infancy for improving bone density
192. Vitamin D with or without calcium for treating osteoporosis in postmenopausal women
193. Vitamin E supplementation for adults with diabetes mellitus
194. Vitamin K for the prevention and treatment of osteoporosis in post-menopausal women
195. Vitamin K for the primary prevention of cardiovascular disease
196. Workplace lighting for improving mood and alertness in daytime workers
197. Xylitol-containing products for preventing dental caries in children and adolescents
198. Yoga for schizophrenia
199. Yoga for stroke rehabilitation